Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-14

Clinical Trial Update: Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid [Phase 4]

View source ↗

Summary

Phase 4 trial comparing add-on dapsone versus add-on methotrexate for efficacy and safety in bullous pemphigoid has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DAPSONE (dapsone)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Bullous Pemphigoid | Phase 4 | Status: COMPLETED